ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the <scp>BET</scp> inhibitor apabetaloneCristina Aguirre‐Portolés, Ana Ramı́rez de Molina|Molecular Oncology|2018Cited by 108
Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cellsRuth Sánchez‐Martínez, Ana Ramı́rez de Molina|Scientific Reports|2017Cited by 75
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancerLara P. Fernández, Ana Ramı́rez de Molina|Molecular Oncology|2020Cited by 55
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistanceLara P. Fernández, Ana Ramı́rez de Molina|Scientific Reports|2018Cited by 50
Precision Nutrition for Targeting Lipid Metabolism in Colorectal CancerCristina Aguirre‐Portolés, Ana Ramı́rez de Molina|Nutrients|2017Cited by 48